tiprankstipranks
Advertisement
Advertisement
Oppenheimer bullish on Prime Medicine, initiates with an Outperform
PremiumThe FlyOppenheimer bullish on Prime Medicine, initiates with an Outperform
3M ago
Prime Medicine initiated with an Outperform at Oppenheimer
Premium
The Fly
Prime Medicine initiated with an Outperform at Oppenheimer
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Prime Medicine updates corporate strategy for Prime Editing platform
PremiumCompany AnnouncementsPrime Medicine updates corporate strategy for Prime Editing platform
5M ago
Ametek, MindMed, Atai, Prime and KB Home Trending
Premium
Weekend Updates
Ametek, MindMed, Atai, Prime and KB Home Trending
5M ago
Prime Medicine initiated with an Outperform at LifeSci Capital
Premium
The Fly
Prime Medicine initiated with an Outperform at LifeSci Capital
5M ago
Cautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
PremiumRatingsCautious Hold Rating for Prime Medicine, Inc. Amid Promising Preclinical Results and Extended Development Timeline
7M ago
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
Premium
Ratings
Prime Medicine’s Promising Advances in Gene Editing Justify Buy Rating
7M ago
Prime Medicine price target lowered to $4.25 from $5 at Citi
Premium
The Fly
Prime Medicine price target lowered to $4.25 from $5 at Citi
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100